معرفی
Dr. Lynn McGarry is an Affiliate researcher at the University of Glasgow's School of Cancer Sciences, based at the Cancer Research UK Scotland Institute (Beatson Institute, Garscube Estate). Her primary affiliation spans the CRUK Scotland Institute and University of Glasgow's cancer research ecosystem.
Her research focuses on cancer metastasis mechanisms, particularly ovarian cancer progression, cell invasion dynamics, and metabolic adaptations in tumors. Key areas include ARF GTPase signaling networks, solute carrier transporters in serine metabolism, and tumor microenvironment interactions. Recent work demonstrates how PTEN deficiency creates dependencies on specific invasion pathways and how omental matrices model metastatic niches.
Analysis of her 15 most recent publications reveals a strong emphasis on metastatic drivers across multiple cancer types (ovarian, liver, pancreatic), with recurring themes in cytoskeletal regulation, lipid signaling, and therapeutic targeting of invasion modules. Her work frequently employs advanced 3D culture models and live imaging to capture dynamic cellular behaviors.
No scientific awards were explicitly mentioned in the source material.
Dr. McGarry actively collaborates across international consortia, with co-authorship on high-impact studies in Nature, Cell, and EMBO journals. Her research program receives substantial funding from Cancer Research UK and other major cancer charities, supporting investigations into metastasis-targeted therapies. She contributes to PhD training through the University of Glasgow's graduate programs.
Her laboratory utilizes cutting-edge approaches including CRISPR screening, intravital imaging, and metabolic profiling to dissect invasion mechanisms. Current projects focus on targeting ARF GTPase modules and solute carriers to block metastatic progression.
